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What the US gets for its investment 
Getting what we pay for? 
Factors driving growth in medical spending 
per case 
Roehrig et al. Health Affairs 2011 
Preventable mortality in the U.S. 
Preventable Deaths per 100,000 population 
Source: Commonwealth Fund 2008 
Geographic variation in preventable 
mortality 
Life Expectancy Differences 
7.2 year gap among males 
4.8 year gap among females 
Research investments & expectations  
Discovery to delivery diffusion 
Events in the diffusion of ECMO technology  
National Institute of Child Health and Human Development, 1990  
Discovery to Delivery Translation 
LAB AND ANIMAL STUDIES 
Failures in T2 Translation: Variation in Use 
Failures in T2 Translation:  
Under-use of effective care 
McGlynn et al. 
2003 
Failures in T2 Translation:  
Under-use of effective care 
McGlynn et al. 
2007 
Failures in T2 Translation:  
Over-use of costly, equivocal care 
Failures in T2 Translation:  
Disparities in care 
Pediatric hospital 
admissions for asthma 
Prenatal care in 1st trimester 
Pneumococcal vaccination 
Children counseled on 
physical activity 
Colorectal CA screening 
Depression treatment 
Failures in T2 Translation:  
Missed opportunities for prevention 
Less than 50% of the population at risk is reached by: 
 Smoking cessation 
 Aspirin use 
 Colorectal cancer screening 
 Influenza vaccines 
 Nutrition and physical activity programming 
A changing paradigm for health research 
 Research often fails to inform the choices faced by 
clinicians, patients, payors, policy-makers  
 Need head-to-head comparisons of all relevant choice 
options and combinations 
 Need evidence on effectiveness in real-world clinical & 
community settings 
 Need to know whether/why interventions work for some 
and not for others (treatment heterogeneity) 
 Need to determine value from the consumer’s perspective 
(patient-centered outcomes and costs) 
 
 
 
CER Defined 
 “Comparative effectiveness research is the generation 
and synthesis of evidence that compares the benefits and 
harms of alternative methods to prevent, diagnose, 
treat, and monitor disease and improve the delivery of 
care.  
 The purpose of CER is to assist consumers, clinicians, 
purchasers, and policy makers to make informed 
decisions that will improve health care at both the 
individual and population levels.” 
 
-National Academy of Sciences  
Institute of Medicine, 2009 
 
 
Fundamental empirical questions 
Which programs, interventions, policies (mechanisms)…. 
Work best (outcomes)… 
In which institutional & community settings (contexts)… 
And why (causal pathways, interactions)?   
Pawson and Tilley 1997; Berwick 2008 
Recent developmental history 
 2003 Medicare Modernization Act: $30M annually for 
research to improve quality, effectiveness, efficiency  
 2007 federal legislation to expand CER passed House  
but failed Senate 
 2009 ARRA:  $1.1B to NIH and AHRQ for CER 
             Federal Coordinating Council for CER established 
             IOM Top 100 Priority Topics for CER identified 
 50% involve health care delivery system 
 33% address health care disparities 
 20% address patient functional limitations or disabilities 
 2010 ACA: $600M annually through Patient Centered 
Outcomes Research Institute 
 
 
 
Methods for CER 
 Require both prospective trials and observational studies 
 Advanced analytic methods used to strengthen internal 
validity and limit bias due to selection, confounding 
 Propensity score and instrumental variables models 
 Explicit testing for treatment heterogeneity 
 Latent variable models for multiple interventions, 
multiple outcomes 
 Non-inferiority analyses 
 Development and integration of large  
clinical and administrative data sources  
and registries  
 Use of Bayesian models for synthesizing  
data from multiple studies, e.g.  
indirect treatment comparisons 
 
Delivery System Innovations & CER 
Triple Aim Goals: 
 Improving individual experience with care 
 Improving population health 
 Reducing per-capita costs of care for populations 
Key Components: 
 Partnerships with individuals, families, communities 
 Redesign of primary care 
 Population health management 
 Financial management 
 Integration across continuum of care 
Delivery System Innovations & CER 
 Patient centered medical home models 
 Community health teams 
 Community health worker models 
 Care transition models 
 Accountable care organizations 
 Bundled payment methods 
 E-health and mobile health applications 
 
Community-Level Research in CER 
Identify community-level factors that affect implementation 
of clinical interventions → effect modifiers 
Estimate effects of complex community-level interventions 
Estimate cumulative effects of multiple interventions  
at the population level 
Study the effects of environmental exposures  
(alone or in combination with clinical interventions) 
Evaluate spill-over effects of clinical interventions  
on larger populations (beyond the treated) 
Study downstream effects of prevention strategies on 
disease prevalence, care-seeking behavior, utilization 
Primary Care & Public Health 
Integration 
 Community Transformation Grants 
 CMMI Community Health Innovation Awards 
 Medicaid-funded Community Health Teams 
 AHRQ Primary Care Extension Program 
 HRSA Public Health Training Centers 
 
Institute of Medicine. 2012.  Primary Care and Public Health: 
Exploring Integration to Improve Population Health.  
Washington DC: National Academies Press.   
Some Examples of Delivery System 
Research and CER 
Example: Testing a delivery system 
innovation to promote VLBW deliveries in 
appropriate settings 
Tele-health support to promote VLBW infants delivered 
at NICU v. non-NICU facilities 
Selection Problem: complex and high-risk cases are 
more likely to be referred to higher-level facilities for 
delivery 
Censoring Problem: facilities may differ in rates of in-
hospital mortality due to case mix and quality 
differences, thereby distorting measures of resource 
use 
Example: Testing a program to promote 
VLBW deliveries in appropriate settings 
Model     IRR-LOS 95% CI 
1. Standard multivariate risk adjustment   
   Tertiary NICU facilities†   1.25  1.23, 1.27 
   Community NICU facilities†  1.32  1.30, 1.34 
2.  Control for mortality censoring 
  Tertiary NICU facilities†   1.13  1.12, 1.15 
 Community NICU facilities†  1.24  1.22, 1.26 
     (In-hospital mortality effect 0.74  0.53, 0.95) 
3.  IV control for hospital selection & mortality 
 Tertiary NICU facilities†   0.93  0.88, 0.98
 Community NICU facilities†  1.17  1.14, 1.20
 (In-hospital mortality  0.23  0.11, 0.36) 
IRR = Adjusted incidence rate ratio, from negative binomial model 
†Reference = Community hospitals without NICU 
Significantly lower resource use when 
deliveries occur at tertiary NICU facilities 
Example: Comparative efficiency of 
community-based vs. institutional long-
term care for elderly/disabled 
CCP program links elderly and disabled Medicaid 
recipients with community-based long-term care 
services to avoid/delay need for institutional care 
Determine the impact of the CCP program on Medicaid 
expenditures for elderly and disabled recipients eligible 
for long-term care services 
Determine whether the CCP program is cost-neutral to 
Medicaid after accounting for both Medicaid 
expenditures and program operating costs 
Methods: Comparison Group 
CCP participants 
Comparison Group: statistically 
matched on age, gender, race, eligibility 
category, enrollment duration, waiver 
enrollment, comorbidities, prior-year 
spending 
Results of propensity score matching 
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Distribution of Propensity Score 
CCP Participants Comparison Group 
Approximate a “statistically equivalent” control group that 
would be generated by random assignment. Each subject has 
an equivalent probability of being a CCP participant.  
Estimates of Program Impact 
Regression-Adjusted Spending Estimates 
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“Communities with larger growth in 
public health spending experienced  
larger reductions in preventable 
mortality rates.” 
Mays et al. Health Affairs 2011 
Example: Reductions in preventable mortality  
attributable to public health spending 
Example: Reductions in medical care 
spending attributable to public health 
investments 
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Quintiles of public health spending/capita
Public health spending/capita
Medical spending per recipient
Spending estimates adjusted for age, comorbidities, and service mix  
Mays et al. Health Services Research 2009 
Advancing Delivery System Research  
with PBRNs 
Use networks to identify, design and test multi-
component interventions: 
Primary care 
Public health 
Dental, etc 
Take advantage of emerging clinical data resources: 
EMRs, registries, linkage to administrative data 
Capitalize on new funding opportunities: CMMI, PCORI, 
AHRQ 
Include a focus on population-level health impact 
